Laboratoire Hra-pharma

Legacy Healthcare Holding Ltd.

The United States of America, As Represented by the Secretary, Department of Health and Human Services

Legacy Healthcare Ltd.

Ulmann, André

Nieman, Lynnette K.

Newman, Arnold L.

André Ulmann

Erin Gainer

Diana Blithe

Lynnette Nieman

Henri Camille Mathe

Luc Massart

Héléne Guillard

Jean-Frédéric Laville

Jean-Frédéric Sturer

Lynnette K Nieman

François Vuillet

Lynette Nieman

Arnold L Newman

The invention relates to a method of contraception, which method comprises administering to a woman in need thereof an emergency contraception during one or two days, followed by a prolonged low dosage contraceptive treatment until next menstrual period.

Method for contraception

Compositions are disclosed containing, as active ingredients, an extract ofspecies, an extract ofspecies and either an extract ofspecies and an extract ofspecies, or an extract ofspecies and zinc sulphate, and the method of preparation of these compositions, and cosmetic and/or pharmaceutical application of these compositions.

Cosmetic and/or pharmaceutical compositions and their applications

The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17&#x3b1;-acetoxy-11&#x3b2;-[4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.

Method for treating uterine fibroids

Growing community of inventors

Paris, France

André Ulmann